|
CD8 Annexin V Levels at Baseline and 6 Years. |
||||||
| % Annexin V levels (mean ± SD) |
Baseline (mean ± SD) |
6 Years (mean ± SD) |
||||
|
|
||||||
| CD4 (cells/mm3) |
CD8 (cells/mm3) |
CD4:CD8 Ratio |
CD4 (cells/mm3) |
CD8 (cells/mm3) |
CD4:CD8 Ratio |
|
|
|
||||||
| Low 2.2 ± 2.1 |
625 ± 221 |
967 ± 386 |
0.76 ± 0.4 |
1209 ± 164 |
915 ± 308 |
1.55 ± 0.9 |
| High 17.0 ± 6.0 |
527 ± 132 |
1234 ± 660 |
0.56 ± 0.36 |
754 ± 320 |
1172 ± 456 |
0.76 ± 0.4 |
| p-value |
p = 0.331 |
p = 0.374 |
p = 0.327 |
p = 0.001 |
p = 0.240 |
p = 0.038 |
|
CD4 values, CD8 values, and CD4:CD8 ratios were recorded at baseline and 6 years for the low and high apoptosis groups. At baseline, a parametric t test showed no significance between low and high CD8 apoptosis levels for CD4, CD8 or CD4:CD8 ratios. However, after 6 years, a significant difference was observed between the high and low annexin groups with respect to CD4 values and CD4:CD8 ratios with p values of ≥ 0.001 and ≥ 0.037. CD8 was not significantly different at any time point. | ||||||
Lewis et al. Journal of Translational Medicine 2007 5:9 doi:10.1186/1479-5876-5-9 |
||||||